RWD70 Impact of COVID-19 on the Utilization of Behavioral Healthcare Services in the US

por Kukreja, I, Mishra, N, Gaur, A, Roy, A, Chopra, A, Gupta, A, Brooks, L, Sulzicki, M, Pandey, S, Verma, V, Field, S, Krebs, B
Publicado 2022

RWD16 Impact of COVID-19 Vaccination in Reducing Average Length of Stay in Hospitals Among COVID-19 Patients in the US - a Retrospective Study from De-Identified Administrative Cla...

por Pandey, N, Verma, V, Chopra, A, Kukreja, I, Gaur, A, Sulzicki, M, Roy, A, Brooks, L, Gupta, A, Pandey, S, Field, S, Krebs, B
Publicado 2022

PCR93 Comprehensibility and Usability of an Electronic COVID-19 Daily Symptom Diary

por Baranov, K, Casstevens, C, McLeroth, P, Merikle, E
Publicado 2022

HSD42 Trends in Non-COVID Healthcare Utilization during the Pandemic in Lebanon

por Alameddine, R, Bassil, Y, Barhoun, J, Asmar, K, Maskineh, C
Publicado 2022

EPH32 Perceived Risk of COVID-19 and Its Association with Preparedness and Preventive Practices: A Latent Class Segmentation Analysis

por Mgbere, O, Iloanusi, S, Yunusa, I, Iloanusi, NJR, Gohil, S, Essien, EJ
Publicado 2022

HSD97 Use Machine Learning (ML) Techniques to Identify the Likelihood of Hospitalization for High-Risk Patients Diagnosed with COVID 19

por Mehta, RR, Uppunuthula, S
Publicado 2022

EE179 Key Drivers of the Economically Justifiable Price of the COVID-19 Vaccine in England

por Aballea, S, Karwala, P, Zerda, I, Toumi, M, Pochopien, M, Borissov, B, Clay, E
Publicado 2022

SA34 Impact of COVID-19 on Telehealth Utilization: Analysis of Komodo Healthcare Map™ Claims Data

por Silber, A, Liu, R, Mulrooney, M, Salkar, M, Francis, K, Hadker, N
Publicado 2022

EE468 Economic Impact of Sequential Testing for COVID-19 and Influenza with Molecular Point of Care in 3 European Countries

por Shafrin, J, Mubayi, A, Birch, K, Land, N, Sotak, M, Venkatachalam, M, Theriou, C, Ayad, M
Publicado 2022

SA16 Technology-Assisted Adaptive Recruitment Strategy for a National Study of Immunogenicity of COVID-19 Vaccines and Levels of Sars-COV-2 Neutralising Antibody in the Bruneian Po...

por Shim, CY, Ghani, H, Ahmad, L, Sharif, H, Alikhan, MF, Bagol, S, Taib, S, Tan, CW, Ong, XM, Wang, LF, Han, GF, Xiao, Y, Song, Y, Wei, Y, Wong, J, Naing, L, Cunningham, AC
Publicado 2022

RWD2 Variation in COVID-19 Treatment Cost due to Social Factors in the US – Estimation Using Integration of CDC/ATSDR’s Social Vulnerability Index (SVI) and Healthcare Claims Data...

por Roy, A, Gaur, A, Gupta, A, Upadhyay, N, Kukreja, I, Chopra, A, Brooks, L, Sulzicki, M, Verma, V, Pandey, S, Field, S, Krebs, B, Nayyar, A
Publicado 2022

SA6 A Review of Economic Evaluation on Vaccination and Non-Pharmaceutical Interventions for COVID-19 Prevention and Control

por Zhao, J, Fu, Y, Han, P, Yang, L
Publicado 2022

HSD49 Variability in Incidence of Circulatory and Endocrinal Complications Post COVID-19

por Choudhary, S, Sethi, A, Verma, V, Brooks, L, Sulzicki, M, Pandey, S, Roy, A, Gaur, A, Chopra, A, Gupta, A, Kukreja, I, Field, S, Krebs, B
Publicado 2022

EE211 Cost of Long COVID Following Severe Disease - a US Healthcare Database Analysis

por Patterson, B, Ruppenkamp, J, Richards, F, Debnath, R, El Khoury, AC, DeMartino, JK, Bookhart, B, Holy, C, Coplan, P
Publicado 2022

CO67 Predictors of Long COVID in Patients with Severe COVID-19 - a US Healthcare Database Analysis

por Holy, C, Patterson, B, Ruppenkamp, J, Richards, F, Debnath, R, DeMartino, JK, Bookhart, B, El Khoury, AC, Coplan, P
Publicado 2022

EPH3 Diabetes and the COVID-19 Epidemic in Algeria: Prevalence and Characteristics of Patients Diagnosed during the First 6 Months of the Epidemic

por Tebaibia, A, Mammeri, A, Brahimi, H, Ammi, M, AitSaid, N, Lebdjiri, M, Grine, S, Tagzout, D, Hadjene, L, Bradaia, H, Hamrour, F, Hocine, O, Hamouni, M, Toudji, N, Aouadi, M, Khedairia, I, Djafour, W, Bouriah, A, Belkadi, A, Bouabana, F
Publicado 2022

EE334 Healthcare Utilization and Charges Associated with US Hospitalized Adult Patients with Coronavirus Disease 2019

por Richards, F, Munoz, B, Fried, MW, Morris, HL, Mospan, AR, Crawford, JM, Patterson, B, Di Scala, L, Holy, C, El Khoury, AC
Publicado 2022

RWD61 Analysis of the National Database of the Russian Federation on the Safety of Medicines for Etiopathogenetic Treatment covid-19 in Clinical Practice (REAL-WORLD DATA; RWD)

por Kolbin, A, Syraeva, GI, Mishinova, SA
Publicado 2022

PCR80 Informing a Conceptual Framework for a Patient-Centered Value Assessment of Emerging Therapies for Mild/Moderate COVID-19

por Ali, C, Mattingly, TJ, Slejko, JF, Dosreis, S
Publicado 2022

EE330 Spill-over of Medical Cost for Blue Cross and Blue Shield of Louisiana Members with Differing Severity of COVID-19 Infection

por Lucas, E, Palanki, S, Liu, M, Barfield, D, Zhang, Y, Vicidomina, B, Mills, S, Nigam, S
Publicado 2022